Generation and persistence of CD4 memory subsets
Generation and persistence of CD4 memory subsets
批准号:
8510180
负责人:
SUSAN L SWAIN
金额:
$0.53万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-22 至 2014-08-31
关键词:
AntibodiesAntigensAutoimmunityB-LymphocytesBehaviorCD4 Positive T LymphocytesCapsid ProteinsCellsCommitCommunicable DiseasesDoseExposure toGenerationsGoalsHeterogeneityImmune responseImmunityImmunizationIn VitroInfectionInfluenzaInstructionInterleukin-10Interleukin-17LearningLungMemoryPlayProductionRegulatory T-LymphocyteRoleSchemeSelectinsStagingStructure of germinal center of lymph nodeT memory cellTuberculosisVaccinesbasechemokinecombatcytokinecytotoxicityfluimprovedin vivoinfluenza virus vaccineinsightmigrationpathogenresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Generation and Persistence of CD4 Memory Subsets
Recently we found that flu-specific CD4 T cell effectors provide protection against lethal challenge by virtue
of both direct cytolytic activity (ThCTL) and help for Ab, suggesting additional functional heterogeneity
among CD4 subsets that may contribute to CD4 memory heterogeneity and help us uncover new
mechanisms of vaccine-induced protection. We have recent evidence that IL-17 producing CD4 also play a
role in combating influenza. Our goal here is to evaluate the hypothesis that ThCTL cells represent a distinct
functionally specialized subset that with Thi and Thi7 participate in an effective immune response. We will
compare ThCTL to Thi7 and Thi subsets at the effector stage to further define their respective functions
and determine how they provide protection in the lung against influenza. We will ask if ThCTL and Thi7 give
rise to committed memory subsets and determine their roles in combatting influenza.
To accomplish these aims we will: 1) Isolate defined CD4 effector subsets generated in vitro and develop a
scheme to separate them when they develop in vivo. We will define their cytokine and chemokine profiles,
their migration and their involvement in help, cytotoxicity and protection against challenge with influenza. We
will use the functional profile to develop a "signature" for each subset;
2) We will determine each subset's ability to give rise to memory cells that respond to challenge and develop
into secondary effectors and ask if they retain the same functional potential as they progressively
differentiate; and 3) We will evaluate the mechanisms used by each memory Th subset to provide protection
against lethal flu challenge.
We will collaborate with: 1) Project 2 to determine which how the CD4 subsets compare with parallel CDS
effector and memory subsets; 2) Project 3 to determine migrafion of the CD4 subsets, and behavior in the
lung and how interactions with selectins regulates function and memory generation from effectors; 3) Project
4 to investigate whether similar TuberculosisAg-speeific CD4 subsets can improve protecfion against
Tuberculosis infecfion.
RELEVANCE (See instructions):
Current vaccines for influenza are based on induction of Ab specific for coat proteins that change each year,
so they provide only short term protecfion. Knowing the mechanisms by which memory T cells provide
immunity, should suggest new CD4 T cell correlates of protection and provide insights that can be used to
develop new strategies for improved vaccines, which could be targeted towards inducing robust T cell
memory, in addition to antibody, so that immunization will be more effective and longlasting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing Age-Associated B cells for a Universal Influenza Vaccine for the Aged
-
批准号:10573680
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2022
-
负责人:SUSAN L SWAIN
-
依托单位:
Age-Associated B Cells Specialized for Immunity to Pathogens?
-
批准号:10218497
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2021
-
负责人:SUSAN L SWAIN
-
依托单位:
Age-Associated B Cells Specialized for Immunity to Pathogens?
-
批准号:10401919
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2021
-
负责人:SUSAN L SWAIN
-
依托单位:
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus
-
批准号:10187518
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2020
-
负责人:SUSAN L SWAIN
-
依托单位:
Impact of TcR Signal Strength at the Effector Checkpoint on Protective CD4 T Cell Immunity to Influenza Virus
-
批准号:10027026
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2020
-
负责人:SUSAN L SWAIN
-
依托单位:
Maintaining Robust T Cell Immunity For Broad Protection Against Influenza
-
批准号:9806329
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2019
-
负责人:SUSAN L SWAIN
-
依托单位:
VACCINE STRATEGIES TO CIRCUMVENT AGE-ASSOCIATED IMMUNE DEFECTS
-
批准号:9762805
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2018
-
负责人:SUSAN L SWAIN
-
依托单位:
Defining a memory checkpoint for CD4 T cells
-
批准号:9064064
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2015
-
负责人:SUSAN L SWAIN
-
依托单位:
Defining a memory checkpoint for CD4 T cells
-
批准号:8938979
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2015
-
负责人:SUSAN L SWAIN
-
依托单位:
Generation and persistence of CD4 memory subsets
-
批准号:8316250
-
项目类别:
-
资助金额:$37.76万
-
财政年份:2011
-
负责人:SUSAN L SWAIN
-
依托单位:
CD4 effector contraction in influenza
-
批准号:8300101
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2011
-
负责人:SUSAN L SWAIN
-
依托单位:
Administration
-
批准号:8316254
-
项目类别:
-
资助金额:$12.71万
-
财政年份:2011
-
负责人:SUSAN L SWAIN
-
依托单位:
CD4 effector contraction in influenza
-
批准号:8217866
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2011
-
负责人:SUSAN L SWAIN
-
依托单位:
FASEB SRC Biology of the Immune System
-
批准号:7907418
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2010
-
负责人:SUSAN L SWAIN
-
依托单位:
Generation and persistence of CD4 memory subsets
-
批准号:8330463
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2010
-
负责人:SUSAN L SWAIN
-
依托单位:
Generation and persistence of CD4 memory subsets
-
批准号:8136582
-
项目类别:
-
资助金额:$41.97万
-
财政年份:2010
-
负责人:SUSAN L SWAIN
-
依托单位:
T Cell Memory to Pathogens: Generation and Function
-
批准号:8317881
-
项目类别:
-
资助金额:$69.51万
-
财政年份:2010
-
负责人:SUSAN L SWAIN
-
依托单位:
Administration
-
批准号:8136586
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2010
-
负责人:SUSAN L SWAIN
-
依托单位:
Administration
-
批准号:8330467
-
项目类别:
-
资助金额:$3.82万
-
财政年份:2010
-
负责人:SUSAN L SWAIN
-
依托单位:
T Cell Memory to Pathogens: Generation and Function
-
批准号:8136588
-
项目类别:
-
资助金额:$185.36万
-
财政年份:2009
-
负责人:SUSAN L SWAIN
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: